Healthcare communication agencies: what they do and how to brief one

A healthcare communication agency, usually called a medical communications or med comms agency, turns clinical and scientific evidence into material that doctors, pharmacists, payers, regulators, patients and the press can use. The work is evidence led rather than persuasion led. Typical services are publication planning and manuscript development, medical education and symposia, congress and advisory board programmes, scientific platforms and narratives, field team training and materials for medical science liaisons, patient education, payer and market access dossiers, and healthcare public relations. It differs from a healthcare marketing agency in both audience and governance: the primary audience is a professional or a payer, and every claim must be supported by a reference and cleared through medical, legal and regulatory review.

This page covers what these agencies do, how they are structured, and how to choose and brief one. For patient facing advertising and demand generation, that sits with a healthcare marketing or advertising agency, and the two often work side by side on the same brand.

Med comms, healthcare marketing and healthcare PR

	Medical communications	Healthcare marketing	Healthcare public relations
Primary audience	Clinicians, researchers, payers, medical societies	Patients, carers, prescribers as customers	Journalists, policy makers, patient groups
Core output	Manuscripts, slide decks, scientific platforms, education, dossiers	Campaigns, websites, media, sales materials	Press material, spokespeople, policy and issues work
Who signs off	Medical affairs, with medical, legal and regulatory review	Commercial, with the same review	Communications and medical, jointly
Measured by	Publications accepted, education reach and comprehension, share of scientific voice	Awareness, enquiries, prescriptions, share	Coverage quality, message pull through, stakeholder position
Dominant constraint	Reference every statement, follow publication and authorship standards	Promotional codes and approved labelling	Accuracy, fair balance, no promotion of unlicensed use

Large groups house all three under one roof with firewalls between commercial and medical teams. Independent agencies tend to specialise, and many clients deliberately keep medical and commercial work with different suppliers so the separation is visible.

The services, in the order a product needs them

Scientific platform and narrative. Before anything is written, the agency builds the evidence story: the unmet need, the mechanism, the data, the gaps, and the statements that the data supports. Everything downstream references this document, which is why a weak platform produces inconsistent material for years.

Publication planning. A mapped sequence of primary manuscripts, secondary analyses, reviews, congress abstracts and posters, with target journals, authors, timings and dependencies. Run to recognised standards for good publication practice, with authorship decided on the accepted international criteria and all writing support disclosed.

Medical writing. Manuscripts, abstracts, posters, oral presentations, plain language summaries, review articles, and the data on file documents that support later claims.

Medical education. Symposia, standalone meetings, accredited programmes, e-learning, and train the trainer material. Independent education has its own grant and governance rules, which the agency should explain without being asked.

Congress programmes. Booth content, satellite symposia, speaker preparation, daily highlights, and a plan for what the field team says in the room.

Advisory boards and insight work. Clinician and payer panels run to a documented purpose, with insights reported in a form that medical affairs can act on.

Field medical support. Slide decks for medical science liaisons, objection handling grounded in the evidence, and response documents for unsolicited questions.

Market access communications. Value dossiers, budget impact summaries, and material tailored to the assessment process of each national or regional payer.

Patient and public material. Plain language versions of the evidence, treatment pathway explanations, and work with patient organisations under a documented relationship.

The governance that shapes the work

These constraints are the reason the discipline exists, and a good agency treats them as the design brief rather than an obstacle.

• Industry codes. In the United Kingdom the ABPI Code of Practice governs promotion and much non promotional activity. Across Europe the EFPIA codes apply, and in the United States the PhRMA Code sits alongside advertising regulation by the Food and Drug Administration. Every market has its own version, and material is cleared market by market.
• Medical, legal and regulatory review. Nothing is published without it. Build review cycles into timelines from the start rather than discovering them at the end.
• Referencing discipline. Every claim carries a citation, and the reference pack travels with the asset.
• Licensed use only. Promotional material speaks only to the approved indication. Scientific exchange has a different and carefully defined scope.
• Transparency. Writing support, funding and conflicts are disclosed in publications. Payments to healthcare professionals are reported under local transparency rules.
• Adverse event reporting. Everyone touching the material, including agency staff, needs pharmacovigilance training and a route to report within the required timeframe.

How to choose one

Ask for these six things and the field narrows quickly:

• Therapy area depth. Named writers with relevant degrees and a publication list in your area. Ask who will actually write, not who presents.
• A publication plan they built, redacted, with what was accepted and where, and what slipped and why.
• Their review process. How they prepare a submission pack so medical, legal and regulatory review passes in fewer rounds. This is where timelines are won or lost.
• Team continuity. Who stays on the account for its life, and the agency's turnover in the relevant team.
• Capacity at congress season. Everyone is busy in the same weeks. Ask how they staff the peak.
• Conflict position. Which competing products they work on and how work is separated.

How to brief one

A brief that produces good work contains: the objective in one sentence, the audience and what they currently believe, the evidence available and its known weaknesses, the claims cleared for use, the markets in scope, the review bodies and their meeting dates, the mandatory references and templates, the budget, and the decision the client wants at the end. Add the three things that would make the programme a success twelve months out. Agencies that are told the destination plan better than agencies handed a task list.

How to judge the work

• Publications submitted, accepted and cited, against the plan and its dates
• Review cycles per asset, which should fall over the first two quarters
• Share of scientific voice at target congresses and in target journals
• Education completion and comprehension, not just attendance
• Field team confidence, measured by asking them which materials they use
• Payer feedback on dossier completeness

The healthcare communication agencies questions worth an answer

What is the difference between a medical communications agency and a healthcare advertising agency?

A med comms agency works primarily with medical affairs on evidence led, largely non promotional material for professional and payer audiences. A healthcare advertising agency works with commercial teams on promotional campaigns within approved labelling. Many brands use both, with clear separation of scope.

Do healthcare communication agencies write for patients too?

Yes, increasingly. Plain language summaries of publications, treatment pathway explainers and disease awareness material are standard services, written to a controlled reading level and reviewed under the same governance.

How are med comms agencies paid?

Usually a mix of retainer for ongoing programmes such as publication planning, and fixed scope project fees for individual assets and meetings. Ask for a scope statement that lists deliverables, rounds of revision and review cycles included, because unlimited revisions is where budgets disappear.

Who owns authorship of a manuscript the agency writes?

Authorship belongs to those who meet the recognised international authorship criteria, which professional writers generally do not. The agency's role is declared as writing support in the acknowledgements, funded by the sponsor. Any agency that is vague about this should be ruled out.

How early should an agency be appointed?

Before pivotal data reads out, so the scientific platform and publication plan are in place and congress deadlines can be met. Appointing after data is available compresses every downstream timeline.

A new audience reading the evidence second hand

Your work produces papers, decks and plain language summaries for clinicians and patients. A new audience reads them second hand: an assistant that summarises the evidence to someone who asked about a condition or a product.

Whether it quotes your client's data accurately depends on how clearly the source pages state it. Ask about a client's product and check the claims, doses and sources in the reply against the approved material. Any gap is a brief for the next round. AI Knows Us asks assistants these questions and lists the sources used.